Healthcare

The Malaysia healthcare outlook addresses the investment opportunities across various segments. The study explores the developments in the hospital industry, IVD and POCT industry, pharmaceutical industry, biotechnology industry, medical devices industry, connected health industry, and the aged care industry in the country. The study explores oppor...

Market development around transparency in the cost of billable outpatient medical services is heating up in 2014, with the Health Care Cost Institute recently announcing a voluntary agreement with the three largest insurers in the US to publish standard charge rates across most CPT assigned services. Price transparency provides the benchmark by w...

The Chinese wound care market is in the growth stage. Growing ageing population and rise in the incidence of lifestyle diseases, coupled with the increase in risk of chronic wounds and in affordability of better quality of wound care products provide the impetus for the Chinese wound care market. Universal coverage of public health insurance scheme...

This issue of Vital Signs, released on August 5, 2014, discusses the Senators plead to the FDA for the quick action regarding draft guidance on laboratory developed tests (LDTs), Synthetic Biologys Series A funding round, Roches investment in Stratos Genomics, and Indias cap on drug prices.

The American Telemedicine Association (ATA) held its annual meeting and tradeshow in Baltimore this past May. The meeting is billed as the worlds largest telemedicine, mHealth, and telehealth meeting and tradeshow. The event is certainly an important venue for trendspotting all thats new and notable in this important and growing industry. Frost...

This issue of Vital Signs, released on July 24, 2014, discusses emerging pharma trends in the Asia Pacific and how the region will act as an anchor to global pharma in coming years, especially in segments such as manufacturing, R&D and clinical trials.

Despite global economic and industry challenges, in vitro diagnostics (IVD) markets are growing robustly at double the rate of the global pharmaceutical industry. The global IVD market size was $47.30 billion in 2013; it is expected to reach $62.63 billion in 2017, at a compound annual growth rate of 7.3%. Because of stagnating mature markets, comp...

This study explores the 2 broad segments of the global endoscopy devices market, namely applications (scopes) and solution components. An in-depth analysis of products/services, applications, and technologies available to end users is provided. The key topics covered include innovations and developments occurring within the endoscopy devices market...